Literature DB >> 11687496

Embryo-derived stem cells: of mice and men.

A G Smith1.   

Abstract

Mouse embryonic stem cells are continuous cell lines derived directly from the fetal founder tissue of the preimplantation embryo. They can be expanded in culture while retaining the functional attributes of pluripotent early embryo cells. In particular, they can participate fully in fetal development when reintroduced into the embryo. The capacity for multilineage differentiation is reproduced in culture where embryonic stem cells can produce a wide range of well-defined cell types. This has stimulated interest in the isolation of analogous cells of human origin. Such human pluripotent stem cells could constitute a renewable source of more differentiated cells that could be employed to replace diseased or damaged tissue by cellular transplantation. In this review, the relationships between mouse embryonic stem cells, resident pluripotent cells in the embryo, and human embryo-derived cell lines are evaluated, and the prospects and challenges of embryo stem cell research are considered.

Entities:  

Mesh:

Year:  2001        PMID: 11687496     DOI: 10.1146/annurev.cellbio.17.1.435

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  331 in total

1.  Understanding the first steps in embryonic stem cell exit from the pluripotent state.

Authors:  C John Luckey; Yu Lu; Jarrod A Marto
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

Review 2.  Dental pulp tissue engineering.

Authors:  Flávio Fernando Demarco; Marcus Cristian Muniz Conde; Bruno Neves Cavalcanti; Luciano Casagrande; Vivien Thiemy Sakai; Jacques Eduardo Nör
Journal:  Braz Dent J       Date:  2011

3.  Signalling in stem cells: meeting on signal transduction determining the fate of stem cells.

Authors:  Lynn E Heasley; Bryon E Petersen
Journal:  EMBO Rep       Date:  2004-02-20       Impact factor: 8.807

4.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

Review 5.  The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency.

Authors:  Petr Svoboda; Matyas Flemr
Journal:  EMBO Rep       Date:  2010-07-23       Impact factor: 8.807

6.  Unraveling the score of the enhancer symphony.

Authors:  Thomas P Zwaka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

7.  Heparan sulfate proteoglycan mediates shear stress-induced endothelial gene expression in mouse embryonic stem cell-derived endothelial cells.

Authors:  Maria Nikmanesh; Zhong-Dong Shi; John M Tarbell
Journal:  Biotechnol Bioeng       Date:  2011-08-31       Impact factor: 4.530

Review 8.  Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine.

Authors:  R Dittrich; M W Beckmann; W Würfel
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

Review 9.  Modern stem cell therapy: approach to disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Lidija Kocbek
Journal:  Wien Klin Wochenschr       Date:  2015-12-10       Impact factor: 1.704

10.  Effect of mitotic inducers and retinoic acid blocker on expression of pluripotent genes in ES cells derived from early stage in vitro-produced embryos in buffalo.

Authors:  Ashok Kumar; Kuldeep Kumar; Renu Singh; Gopal Puri; R Ranjan; T Yasotha; R K Singh; M Sarkar; Sadhan Bag
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-10-24       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.